GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.
Headquarters
United Kingdom
Address
980 Great West Road, Brentford, TW89GS
Website
www.gsk.com
Telephone
44 20 80475000
No of Employees
90,096
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
GSK (LON)
Revenue (2021)
$46.9B
0%
(2021 vs 2020)
EPS
XXX
Net Income (2021)
XXX
-23.7%
(2021 vs 2020)
Market Cap*
$106.4B
Net Profit Margin (2021)
XXX
-23.8%
(2021 vs 2020)
* As of and is in US$
Explore premium data & analytics
Products and Services
| Products | Brands |
|---|---|
| Prescription Medicines | Advair |
| Vaccines | Coreg |
| Consumer Healthcare Products | Epzicom |
| XXX | XXX |
| XXX | XXX |
| XXX | XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | Others | In June, the company announced positive headline results from a pre-specified efficacy interim analysis of the AReSVi 006 phase III trial. |
| 2022 | Plans/Strategy | In June, the company's Haleon announced its plans to sell its 32% stake held by Pfizer. |
| 2022 | Contracts/Agreements | In June, GSK Consumer Healthcare and Ascential Digital Commerce entered into a partnership to launch Ascential Digital Commerce Connect, a first-of-its-kind, data-rich, digital commerce platform. |
Competitor Comparison
| Key Parameters | GSK plc | Johnson & Johnson | Pfizer Inc | F. Hoffmann-La Roche Ltd | AbbVie Inc |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | United States of America | United States of America | Switzerland | United States of America |
| City | Brentford | New Brunswick | New York | Basel | North Chicago |
| State/Province | - | New Jersey | New York | - | Illinois |
| No. of Employees | 90,096 | 141,700 | 79,000 | 100,920 | 50,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Operating Margin
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Dame Emma Walmsley | Director; Chief Executive Officer | Executive Board | 2017 | - |
| Iain Mackay | Director; Chief Financial Officer | Executive Board | 2019 | - |
| Dr. Hal Barron | Chief Scientific Officer; President - R&D; Director | Executive Board | 2018 | - |
| David Redfern | Chief Strategy Officer | Senior Management | 2008 | - |
| Tony Wood | Chief Scientific Officer - Designate | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer